Senior Clinical Quality Compliance and Policy Leader
Roche
Summary
As a Quality Partner within Early Clinical Development (ECD) Quality, you will champion a proactive, risk-based quality culture that enables innovative science to move safely and efficiently to patients. You will serve as the primary Good Clinical Practice (GCP) quality advisor and strategic partner to early-stage clinical trial study teams and external partners. In this role, you will embed quality by design across cutting-edge Early Development clinical programs, resolving complex compliance challenges before they impact study timelines or regulatory integrity.
Job description
The Opportunity
As a Quality Partner within Early Clinical Development (ECD) Quality, you will champion a proactive, risk-based quality culture that enables innovative science to move safely and efficiently to patients. You will serve as the primary Good Clinical Practice (GCP) quality advisor and strategic partner to early-stage clinical trial study teams and external partners. In this role, you will embed quality by design across cutting-edge Early Development clinical programs, resolving complex compliance challenges before they impact study timelines or regulatory integrity.
- Develop strategic partnerships with cross-functional teams in Early Clinical Development (ECD) and external vendor partners to advance compliance solutions and enable transparent issue resolution.
- Provide expert GCP quality guidance, direction, and proactive risk-mitigation strategies to support early clinical trial conduct.
- Support and participate in intradepartmental, global, and cross-functional initiatives, working groups, and project teams as a key decision-maker or lead reviewer.
- Support or lead Quality Management System (QMS) activities, including controlled document management, strategic reviews and process alignment.
- Embed quality principles throughout the organization by delivering impactful compliance communications and targeted training to multidisciplinary teams.
- Collaborate on quality compliance checks and desktop assessments to evaluate clinical trial oversight and data integrity.
- Guide clinical study teams through root cause analysis, deviation management, and Corrective Action/Preventative Action (CAPA) plan development.
Who you are
- You bring a Bachelor’s degree in a life science, healthcare, or related discipline (advanced degree such as MS, PhD, JD, or MD welcomed).
- You possess 5–8 years of experience in pharmaceutical drug development (or 4–6 years with a Master’s; 3–5 years with a PhD, JD, or MD), with a minimum of 6 years dedicated to a GCP-related discipline or Quality Assurance role.
- You hold comprehensive working knowledge of Good Clinical Practice (GCP), ICH guidelines, and global regulatory frameworks and how to apply them to clinical trial conduct.
- You bring proven analytical and problem-solving skills, with a track record of identifying compliance risks, facilitating root cause analyses, and architecting practical CAPA solutions.
- You excel at cross-functional collaboration and stakeholder management, with the ability to translate regulatory requirements into clear, actionable guidance while managing priorities independently.
Preferred
- Direct experience supporting Early Clinical Development (ECD) or first-in-human (Phase I/Ib) clinical trials.
- Hands-on experience with Health Authority inspection preparedness, sponsor/site inspection hosting, and response strategy development (e.g., FDA, EMA).
- Demonstrated experience with external vendor/CRO quality oversight, audits, and desktop assessments.
- Background in supporting Quality Management System (QMS) processes and procedural documents.
- Professional certifications in clinical research or quality assurance (e.g., RQAP-GCP, RAC, SQA).
Location
- This role is based in South San Francisco and offers a hybrid schedule working 3 day per week on campus
- No relocation benefits are available for this posting
Requirements
- Bachelor’s degree in a life science, healthcare, or related discipline
- 5–8 years of experience in pharmaceutical drug development (or 4–6 years with a Master’s; 3–5 years with a PhD, JD, or MD)
- Minimum of 6 years dedicated to a GCP-related discipline or Quality Assurance role
- Comprehensive working knowledge of Good Clinical Practice (GCP), ICH guidelines, and global regulatory frameworks
- Proven analytical and problem-solving skills
- Track record of identifying compliance risks, facilitating root cause analyses, and architecting practical CAPA solutions
- Cross-functional collaboration and stakeholder management skills
- Ability to translate regulatory requirements into clear, actionable guidance
- Ability to manage priorities independently
Benefits
- Hybrid schedule (3 days on campus)
- No relocation benefits
- Discretionary annual bonus
- Benefits package
Company overview
Roche is a Swiss multinational healthcare company and a global pioneer in pharmaceuticals and diagnostics, founded in 1896 and headquartered in Basel, Switzerland. As the world's largest biotech company and the fifth-largest pharmaceutical company by revenue, Roche operates through two primary divisions: Pharmaceuticals and Diagnostics. The company is renowned for its leadership in personalized healthcare, combining strengths in both drug development and diagnostic testing to deliver tailored treatments for patients. Roche maintains a strong focus on oncology, immunology, infectious diseases, ophthalmology, and central nervous system disorders, with a portfolio that includes over 30 medicines on the World Health Organization's Model Lists of Essential Medicines. The company owns significant subsidiaries including Genentech, Chugai Pharmaceuticals, Ventana Medical Systems, and Foundation Medicine. With approximately 103,000 employees worldwide and operations in over 100 countries, Roche has established itself as a leader in cancer treatments globally while maintaining a robust pipeline of innovative therapies and diagnostic solutions. The company's commitment to sustainability has been recognized through ten consecutive years as Group Leader in the Dow Jones Sustainability Indices within the Pharmaceuticals, Biotechnology & Life Sciences Industry.